| Jul 24 |
Why BioMarin (BMRN) is Poised to Beat Earnings Estimates Again
|
| Jul 24 |
BioMarin Pharmaceutical: Steady Performer Scheduling Its Big Reveal In 09/2024
|
| Jul 23 |
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for
|
| Jul 23 |
BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET
|
| Jul 22 |
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release
|
| Jul 18 |
Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
|
| Jul 15 |
Is The Options Market Predicting A Spike In BioMarin Pharmaceutical (BMRN) Stock?
|
| Jul 12 |
Three US Stocks Estimated To Be Trading Below Their Intrinsic Values In July 2024
|
| Jul 9 |
BMO sees BMRN, LEGN, SLN as attractive M&A targets
|
| Jul 4 |
Peering Into Biomarin Pharmaceutical's Recent Short Interest
|
